Browse by Medical Category
Back to Radiochemistry Program
Neil Vasdev, PhD
Director of Radiochemistry, MGHAssociate Director, Gordon Center for Molecular Imaging, MGH Associate Professor of Radiology, HMS
Dr. Neil Vasdev was recruited as the Director of Radiochemistry at Massachusetts General Hospital in 2011 and is an Associate Professor in the Department of Radiology at Harvard Medical School. He concurrently graduated (summa cum laude) with a Bachelor of Science in Chemistry and Bachelor of Arts in Psychology from McMaster University in 1998, under the co-supervision of Prof. Raman Chirakal and Prof. Gary Schrobilgen. Prior to starting graduate school he gained experience working in industry as a chemist at two major pharmaceutical companies: Astra Pharma and Glaxo Wellcome, and a radiopharmacy. In 2002, he completed his Ph.D. dissertation in PET radiopharmaceutical chemistry where he developed new agents to image the living human brain as well as several cancers, while holding a national scholarship (Natural Sciences and Engineering Research Council of Canada (NSERC)). He completed an NSERC postdoctoral fellowship to further his training in PET radiopharmaceutical chemistry in the Department of Functional Imaging at the E.O. Lawrence Berkeley National Laboratory, under the supervision of Prof. Henry VanBrocklin. In 2004, he started his independent research career the University of Toronto’s Department of Psychiatry and the PET group at the Centre for Addiction and Mental Health, where he worked closely under the mentorship of Prof. Alan Wilson. He has focused his radiopharmaceutical chemistry research on developing radiolabelled imaging agents, often by multi-step radiochemistry reactions, for investigating disorders of the human brain and has extended this technology to prepare cancer imaging agents. Several of the radiotracers developed by his laboratory are in preclinical use worldwide and many of these compounds have been used for first in human neuroimaging studies.
Neil has received many academic, teaching and presentation awards for his research. He has been an active member of several national and international chemistry and nuclear medicine societies, including the Society of Nuclear Medicine and Molecular Imaging (SNMMI), and regularly organizes symposia for the Canadian Society for Chemistry and the American Chemical Society. His distinctions include the First Place Young Investigators Award (2006) from the Radiopharmaceutical Sciences Council of the SNM, as well as young investigator awards from the University of Toronto, Ontario Ministry for Research and Innovation, and the Canadian Society of Nuclear Medicine.To see a list of selected publications, visit Neil's profile on Harvard Catalyst
Back to Top